<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2019.7201</article-id>
<article-id pub-id-type="publisher-id">ETM-0-0-7201</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondrial separation protein inhibitor inhibits cell apoptosis in rat lungs during intermittent hypoxia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Dan</given-names></name>
<xref rid="af1-etm-0-0-7201" ref-type="aff">1</xref>
<xref rid="af2-etm-0-0-7201" ref-type="aff">2</xref>
<xref rid="fn1-etm-0-0-7201" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Yin</surname><given-names>Chen-Yi</given-names></name>
<xref rid="af3-etm-0-0-7201" ref-type="aff">3</xref>
<xref rid="fn1-etm-0-0-7201" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Ye</surname><given-names>Xian-Wei</given-names></name>
<xref rid="af1-etm-0-0-7201" ref-type="aff">1</xref>
<xref rid="fn1-etm-0-0-7201" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Wan</surname><given-names>Zi-Fen</given-names></name>
<xref rid="af1-etm-0-0-7201" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhao</surname><given-names>De-Gang</given-names></name>
<xref rid="af2-etm-0-0-7201" ref-type="aff">2</xref>
<xref rid="af4-etm-0-0-7201" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xiang-Yan</given-names></name>
<xref rid="af1-etm-0-0-7201" ref-type="aff">1</xref>
<xref rid="c1-etm-0-0-7201" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-etm-0-0-7201"><label>1</label>Department of Respiratory and Critical Care Medicine, Guizhou Provincial People&#x0027;s Hospital, Guiyang, Guizhou 550002, P.R. China</aff>
<aff id="af2-etm-0-0-7201"><label>2</label>Life Sciences College of Guizhou University, Guiyang, Guizhou 550025, P.R. China</aff>
<aff id="af3-etm-0-0-7201"><label>3</label>Department of Graduate School, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China</aff>
<aff id="af4-etm-0-0-7201"><label>4</label>The Key Laboratory of Plant Resources Conservation and Germplasm Innovation in Mountainous Region (Ministry of Education), Guizhou University, Guiyang, Guizhou 550025, P.R. China</aff>
<author-notes>
<corresp id="c1-etm-0-0-7201"><italic>Correspondence to</italic>: Professor Xiang-Yan Zhang, Department of Respiratory and Critical Care Medicine, Guizhou Provincial People&#x0027;s Hospital, 83 ZhongShan East Road, Guiyang, Guizhou 550002, P.R. China, E-mail: <email>zxy35762@126.com</email></corresp>
<fn id="fn1-etm-0-0-7201"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub">
<month>03</month>
<year>2019</year></pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>01</month>
<year>2019</year></pub-date>
<volume>17</volume>
<issue>3</issue>
<fpage>2349</fpage>
<lpage>2358</lpage>
<history>
<date date-type="received"><day>23</day><month>04</month><year>2018</year></date>
<date date-type="accepted"><day>22</day><month>11</month><year>2018</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2019, Spandidos Publications</copyright-statement>
<copyright-year>2019</copyright-year>
</permissions>
<abstract>
<p>Obstructive sleep apnoea (OSA) is a very common sleep and breathing disorder that occurs in worldwide. It is important to develop a more effective treatment for OSA to overcome lung cell apoptosis during intermittent hypoxia (IH). A mitochondrial separation protein inhibitor (Mdivi-1) has been demonstrated to be a powerful tool for inhibiting apoptosis. In the present study, the protective effect and possible mechanism of apoptosis in lung cells during IH was investigated using <italic>in vivo</italic> and <italic>in vitro</italic> experiments. Following IH exposure for 4 weeks, the lung tissues of Sprague Dawley rats exhibited interstitial lesions, while Mdivi-1 reduced these pulmonary interstitial lesions. B-cell lymphoma (Bcl)-2 mRNA and protein expression levels were decreased however caspase-3, caspase-9 and dynamin-related protein 1 (Drp-1) mRNA and protein expression levels were increased. Following Mdivi-1 intervention, Bcl-2 mRNA and protein expression levels were increased while caspase-3, caspase-9 and Drp-1 mRNA and protein expression levels were decreased (P&#x003C;0.05). After exposure to IH for 12 h, the apoptosis rate of WTRL1 cells in rats increased gradually with the IH time (P&#x003C;0.05). Bcl-2 mRNA and protein expression levels were decreased, whereas caspase-3, caspase-9, cytochrome C (Cyt-C) and Drp-1 mRNA levels were increased, and caspase-3, caspase-9 and Drp-1 protein expression levels were increased. After Mdivi-1 intervention, Bcl-2 mRNA and protein expression levels were increased but caspase-3, caspase-9, Cyt-C and Drp-1 mRNA levels were decreased along with caspase-9, Cyt-C and Drp-1 protein expression levels which were decreased (P&#x003C;0.05). The results of the present study suggest that Mdivi-1 may be a potential agent for treating OSA because it inhibits the mitochondrial pathway and reduces apoptosis.</p>
</abstract>
<kwd-group>
<kwd>mitochondrial division inhibitor-1</kwd>
<kwd>lung</kwd>
<kwd>cell apoptosis</kwd>
<kwd>intermittent hypoxia</kwd>
<kwd>mitochondrial signalling pathways</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Obstructive sleep apnoea (OSA) is a very common sleep and breathing disorder that is characterized by the repetitive collapse of the upper airway during sleep (<xref rid="b1-etm-0-0-7201" ref-type="bibr">1</xref>); in addition, OSA has high morbidity in paediatric and adult populations. In OSA, upper airway obstruction is usually associated with recurrent hypoxemia interspersed with periods of reoxygenation and is typically terminated by brief arousals, resulting in intermittent hypoxia (IH) and sleep fragmentation (<xref rid="b2-etm-0-0-7201" ref-type="bibr">2</xref>). The oscillatory nature of IH, especially chronic IH, may mimic the paradigm of ischaemia-reperfusion in that tissues and cells are exposed to periods of low and high O<sub>2</sub>, which may lead to oxidative stress and induces lipid peroxidation, apoptosis, stress-responsive proteins, cell death and inflammation (<xref rid="b3-etm-0-0-7201" ref-type="bibr">3</xref>&#x2013;<xref rid="b5-etm-0-0-7201" ref-type="bibr">5</xref>). Studies have confirmed that IH via different signalling pathways induces cell apoptosis (<xref rid="b6-etm-0-0-7201" ref-type="bibr">6</xref>,<xref rid="b7-etm-0-0-7201" ref-type="bibr">7</xref>). Mitochondrial separation protein inhibitor (Mdivi-1) is a selective dynamin-related protein 1 (Drp-1) inhibitor that has been reported to be a potential therapeutic target for brain, cardiovascular, liver and tumour angiogenesis (<xref rid="b8-etm-0-0-7201" ref-type="bibr">8</xref>,<xref rid="b9-etm-0-0-7201" ref-type="bibr">9</xref>). How Mdivi-1 inhibits lung apoptosis during IH remains unclear. The aim of the present study was to investigate the protective effect and possible mechanism of Mdivi-1 in lung cell apoptosis during IH.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Animals</title>
<p>A total of 32 specific pathogen free 6&#x2013;8-week-old male Sprague Dawley (SD) rats (body weight, 180&#x2013;220 g) were purchased from the Animal Care and Use Committee of the Army Medical University (Chongqing, China). The experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (<xref rid="b10-etm-0-0-7201" ref-type="bibr">10</xref>). All experimental procedures were approved by the Ethics Committee of Guizhou Provincial People&#x0027;s Hospital (Guiyang, China). All efforts were made to minimize animal suffering and to reduce the number of animals used.</p>
</sec>
<sec>
<title>In vivo experimental design</title>
<p>All animals were maintained in a controlled environment (22&#x2013;25&#x00B0;C, 40&#x2013;60&#x0025; relative humidity, with a 12-h light-dark cycle with the lights on at 08:00 am) with food and water available. Animals were allowed to acclimatize for 1 week to the experimental chamber. The rats were allocated randomly to four groups: Control group (n=8), IH group (n=8), IH&#x002B;25 mg/kg Mdivi-1 group (n=8) and IH&#x002B;50 mg/kg Mdivi-1 group (n=8). The rats in the IH group, IH&#x002B;25 mg/kg Mdivi-1 group and IH&#x002B;50 mg/kg Mdivi-1 group were exposed to IH conditions (21&#x0025; O<sub>2</sub>, 5&#x0025; CO<sub>2</sub> and balanced N<sub>2</sub>) for 90 sec and hypoxia (8&#x0025; O<sub>2</sub>, 5&#x0025; CO<sub>2</sub> and balanced N<sub>2</sub> for 30 sec) from 08:00 am to 04:00 pm daily for 4 consecutive weeks (<xref rid="b11-etm-0-0-7201" ref-type="bibr">11</xref>&#x2013;<xref rid="b13-etm-0-0-7201" ref-type="bibr">13</xref>). The chambers had a rear N<sub>2</sub> inlet and a front air extractor, which enabled recovery to normoxia. A computerized system controlled the valve inlets and the alternating cycles of the extractors. The CO<sub>2</sub> in the chamber was maintained at a low level by continuous air extraction (<xref rid="b14-etm-0-0-7201" ref-type="bibr">14</xref>). Rats in the control group were maintained under normoxic conditions during the experiment. The treatment groups were injected intraperitoneally with Mdivi-1 (MedChemExpress, Monmouth Junction, NJ, USA) prior to oxygen treatment every day (<xref rid="b15-etm-0-0-7201" ref-type="bibr">15</xref>). A general clinical pain score for scoring cyanosis condition for decisions about endpoint was use as presented in <xref rid="tI-etm-0-0-7201" ref-type="table">Table I</xref> (<xref rid="b16-etm-0-0-7201" ref-type="bibr">16</xref>).</p>
</sec>
<sec>
<title>Sample collection and tissue preparation</title>
<p>Trained personnel euthanized the experimental animals via CO<sub>2</sub> inhalation following IH exposure. Rats were left in the chamber until clinical death could be ensured. The flow rate of CO<sub>2</sub> displaced 20&#x0025; of the volume chamber per minute. If no breath was seen for 60 sec the rodent was removed from the chamber. To ensure death, the rat&#x0027;s chest was felt to determine that there is no longer a heartbeat. Death was verified following euthanasia and prior to disposal. The lungs were dissected out and the right lower lobes were fixed in 4&#x0025; paraformaldehyde at room temperature for 48 h. The remaining lung tissues were frozen in liquid nitrogen and then stored at &#x2212;80&#x00B0;C until further analysis.</p>
</sec>
<sec>
<title>Histological examination</title>
<p>The right lower lobes were fixed in 4&#x0025; paraformaldehyde at room temperature for 24 h, embedded in paraffin blocks and slices into 6-&#x00B5;m-thick sections. The sections were then stained with haematoxylin for 5 min and eosin for 90 sec at room temperature, and observed by light microscopy. Damage to the lung tissue was scored by the pathologist on a scale of 1 (no injury) to 4 (worst), as described previously (<xref rid="b17-etm-0-0-7201" ref-type="bibr">17</xref>).</p>
</sec>
<sec>
<title>In vitro experimental design</title>
<p>WTRL1 cells (a rat pulmonary alveolar epithelial cell line; <uri xlink:href="http://www.cellresource.cn/fdetail.aspx?id=1349">http://www.cellresource.cn/fdetail.aspx?id=1349</uri>) were purchased from the National Infrastructure of Cell Line Resource, (Beijing, China). The cells were grown in RPMI-1640 medium (HyClone, Logan, UT, USA) with 10&#x0025; FBS (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA), penicillin (100 units/ml) and streptomycin (100 &#x00B5;g/ml) and were cultured at 37&#x00B0;C in 5&#x0025; CO<sub>2</sub> in a humidified incubator. WTRL1 cells in the logarithmic growth phase were divided randomly into five groups (3&#x00D7;10<sup>6</sup> cells/well) in 6-well plates: Control, IH, IH&#x002B;10 &#x00B5;M Mdivi-1, IH&#x002B;50 &#x00B5;M Mdivi-1 and IH&#x002B;100 &#x00B5;M Mdivi-1. The control group was exposed to air, while the IH group, IH&#x002B;10 &#x00B5;M Mdivi-1 group, IH&#x002B;50 &#x00B5;M Mdivi-1 group and IH&#x002B;100 &#x00B5;M Mdivi-1 group were placed in a low oxygen culture box containing 5&#x0025; O<sub>2</sub> for 1 h. The box was then reoxygenated with 21&#x0025; O<sub>2</sub> for 30 min and this process was repeated for 12 h. The treatment groups were incubated with Mdivi-1 for 30 min prior to IH culture.</p>
</sec>
<sec>
<title>Flow cytometry</title>
<p>WTRL1 cells were grown logarithmically and placed on 60-mm Petri dishes in a low oxygen culture box containing 5&#x0025; O<sub>2</sub> for 1 h. The box was reoxygenated with 21&#x0025; O<sub>2</sub> for 30 min and this process was repeated for 6, 12, 24 and 48 h. Next, the cells were resuspended in Annexin V-PI from a dual-staining assay kit (Nanjing KeyGen Biotech. Co. Ltd., Nanjing, China) for 10 min at room temperature. The fluorescence signals from Annexin V and PI were measured by flow cytometry with a FACSCalibur<sup>&#x2122;</sup> flow cytometer (BD Bioscience), and the data were analysed using Cell Quest Pro software (version 5.0; BD Bioscience). The flow cytometry results were measured in 1 h.</p>
</sec>
<sec>
<title>Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)</title>
<p>Total RNA was extracted from lung tissues or cells with TRIzol (Thermo Fisher Scientific, Inc.). The D260/D280 ratio was measured and samples with a ratio between 1.8 and 2.0 were used for reverse transcription with a High Capacity cDNA Archive kit (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The reverse transcription protocol were as follows: 25&#x00B0;C for 10 min, 37&#x00B0;C for 120 min and 85&#x00B0;C for 5 min. qPCR was applied to analyze the cDNAs by using the 2X Maxima SYBR-Green/ROX qPCR Master Mix kit (Thermo Fisher Scientific, Inc.) following the manufacturer&#x0027;s protocol. The amplification conditions were as follows: 95&#x00B0;C for 10 min for denaturation, followed by 40 cycles of 95&#x00B0;C for 15 sec, 60&#x00B0;C for 30 sec and 72&#x00B0;C for 60 sec. qPCR for Bcl-2, caspase-3, caspase-9, Cyt-C and Drp-1 was performed using TaqMan gene expression assays and the 2<sup>&#x2212;&#x0394;&#x0394;Cq</sup> method with GAPDH as the endogenous control (<xref rid="b18-etm-0-0-7201" ref-type="bibr">18</xref>). The primers were synthesized by Sheng Gong (Shanghai) Co., Ltd. (Shanghai, China) and the sequences are presented in <xref rid="tII-etm-0-0-7201" ref-type="table">Table II</xref>.</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>Total protein cell lysates were isolated from rat lungs or from cells as described previously (<xref rid="b19-etm-0-0-7201" ref-type="bibr">19</xref>). Protein quantification was assessed using a bicinchoninic acid protein quantification assay and absorbance read at 562 nm was used to determine sample volumes for further analysis. A total of 50 &#x00B5;g total protein from each tissue homogenate was separated by 30&#x0025; SDS-PAGE and then transferred to polyvinylidene difluoride membranes, which were blocked with 5&#x0025; skim milk at room temperature for 1 h. Membranes were washed twice with TBST and incubated with primary antibodies at 4&#x00B0;C overnight against Bcl-2 polyclonal antibody (cat. no. YT0470), caspase-3 polyclonal antibody (cat. no. YT0656), caspase-9 polyclonal antibody (cat. no. YT0662), Drp1 Polyclonal antibody (cat. no. YT1414; all 1:1,000; ImmunoWay Biotechnology Company, Plano, TX, USA), Cyt-C antibody (cat. no. 10993-1-AP; 1:1,000; ProteinTech, Group, Inc., Chicago, IL, USA), mouse monoclonal &#x03B2;-actin antibody (1:4,000; cat. no. YM3138; ImmunoWay Biotechnology Company). Membranes were washed twice and incubated with horseradish peroxidase-conjugated goat anti-mouse IgG (1:6,000; cat. no. PMK-014-091; Bioprimacy, Wuhan, China) and goat anti-rabbit IgG (1:8,000; cat. no. PMK-014-090; Bioprimacy, Wuhan, China) for 2 h at room temperature. The blots were visualized with eECL western blot kit (Beyotime Institute of Biotechnology, Jiangsu, China). The intensities of the bands were measured using ImageLab 5.1 Software (Bio-Rad Laboratories, Inc.). Rat <italic>&#x03B2;</italic>-actin was used as the loading control in western blotting.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All experiments were repeated three times. All data are presented as mean &#x00B1; standard deviation. Comparisons of two or three experimental conditions were evaluated using an unpaired Student&#x0027;s t-test or one-way analysis of variance and the Bonferroni t-test followed by the Bonferroni post-test using GraphPad Prism 5.0 software (GraphPad Software Corp, San Diego, CA, USA). P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Lung histopathology</title>
<p>Histopathological examinations were performed for the lungs of rats subjected to normoxia, IH, IH&#x002B;25 mg/kg Mdivi-1 and IH&#x002B;50 mg/kg Mdivi-1. IH caused severe interstitial pneumonia and a large number of inflammatory cells, while following Mdivi-1 intervention, interstitial pneumonia and inflammatory cells were reduced. The effect in the IH&#x002B;50 mg/kg Mdivi-1 was more obvious compared with in the IH&#x002B;25 mg/kg Mdivi-1 group (<xref rid="f1-etm-0-0-7201" ref-type="fig">Fig. 1</xref>). Consistent with these histopathological observations, the lung injury score in the IH group was significantly increased compared with the control group (P&#x003C;0.005) and the score in the IH&#x002B;50 mg/kg Mdivi-1 group was significantly decreased compared with in the IH group (P&#x003C;0.005).</p>
</sec>
<sec>
<title>Detection of Bcl-2, caspase-3, caspase-9, Cyt-C and Drp-1 expression levels via RT-qPCR</title>
<p>After SD rats were exposed to IH for 4 weeks and after WTRL1 cells were exposed to IH for 12 h in culture, the expression of apoptosis markers was increased at the gene level in the rat lung tissue cells and WRTL1 cells. In addition, Mdivi-1 treatment effectively reduced the apoptosis rate of the hypoxia-exposed cells. After SD rats were exposed to IH for 4 weeks, Bcl-2 mRNA levels were significantly decreased (P&#x003C;0.05; <xref rid="f2-etm-0-0-7201" ref-type="fig">Fig. 2A</xref>), but caspase-3 and caspase-9 mRNA levels were significantly increased compared with the control group rats (P&#x003C;0.05; <xref rid="f2-etm-0-0-7201" ref-type="fig">Fig. 2B and C</xref>). After Mdivi-1 intervention, Bcl-2 mRNA levels were significantly increased and caspase-3, and Drp-1 mRNA levels were significantly decreased in the IH&#x002B;50 mg/kg Mdivi-1 group compared with the IH group (P&#x003C;0.05; <xref rid="f2-etm-0-0-7201" ref-type="fig">Fig. 2A, B and D</xref>). However, no significant difference in Cyt C levels was identified between the groups (<xref rid="f2-etm-0-0-7201" ref-type="fig">Fig. 2E</xref>). After WTRL1 cells were exposed to IH for 12 h, Bcl-2 mRNA levels were significantly decreased, but caspase-3, caspase-9, Cyt-C and Drp-1 mRNA levels were significantly increased compared with the control group (P&#x003C;0.05; <xref rid="f3-etm-0-0-7201" ref-type="fig">Fig. 3A-E</xref>). After Mdivi-1 intervention, Bcl-2 mRNA levels were significantly increased and caspase-3, caspase-9, Cyt-C and Drp-1 mRNA levels were significantly decreased compared with in the IH group (P&#x003C;0.05).</p>
</sec>
<sec>
<title>Western blotting results for Bcl-2, caspase-3, caspase-9, Drp-1 and Cyt-C</title>
<p>After SD rats were exposed to IH for 4 weeks and after WTRL1 cells were exposed to IH for 12 h in culture, the expression of apoptosis markers was increased at the protein level in rat lung tissue cells and WRTL1 cells. In addition, Mdivi-1 treatment reduced the apoptosis rate of the hypoxia-exposed cells. Western blotting results for Bcl-2, caspase-3, caspase-9, Cyt-C and Drp-1 protein expression in rat lungs are presented in <xref rid="f4-etm-0-0-7201" ref-type="fig">Fig. 4</xref>. After SD rats were exposed to IH for 4 weeks, the protein expression of Bcl-2 in the IH group was significantly decreased, but the protein expression of caspase-3, caspase-9 and Drp-1 was significantly increased compared with the control group (P&#x003C;0.05; <xref rid="f4-etm-0-0-7201" ref-type="fig">Fig. 4A-E</xref>). After Mdivi-1 intervention, the protein expression of Bcl-2 was significantly increased and the protein expression of caspase-3, caspase-9, and Drp-1 was significantly decreased in the IH&#x002B;50 mg/kg Mdivi-1 group compared with the IH group (P&#x003C;0.05). After WTRL1 cells were exposed to IH for 12 h, Bcl-2 protein expression was significantly decreased in the IH group and caspase-3, caspase-9 and Drp-1 protein expression was significantly increased (P&#x003C;0.05; <xref rid="f5-etm-0-0-7201" ref-type="fig">Fig. 5A-E</xref>). After Mdivi-1 intervention, Bcl-2 protein expression was significantly increased and caspase-9, Cyt-C, and Drp-1 protein expression was significantly decreased in the IH&#x002B;100 &#x00B5;M Mdivi-1 group (P&#x003C;0.05; <xref rid="f5-etm-0-0-7201" ref-type="fig">Fig. 5 A, B and D-F</xref>).</p>
</sec>
<sec>
<title>Detection of apoptosis levels</title>
<p>The apoptosis rate of WTRL1 cells was positively correlated with the time of exposure to IH. After WTRL1 cell exposure to IH for 6, 12, 24 and 48 h, the rate of apoptosis in WTRL1 cells increased gradually with the IH exposure time, and the apoptosis rate was the highest at 48 h (P&#x003C;0.05; <xref rid="f6-etm-0-0-7201" ref-type="fig">Fig. 6</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>OSA is characterized by intermittent airway obstruction and systemic hypoxia during sleep. OSA affects 5&#x2013;25&#x0025; of the general population. However, previous studies have illustrated a rising prevalence of moderate-to-severe sleep disordered breathing in men (ranging from 10&#x2013;49&#x0025;, depending on age and cohort) and women (ranging from 10&#x2013;23&#x0025;) in western countries (<xref rid="b20-etm-0-0-7201" ref-type="bibr">20</xref>,<xref rid="b21-etm-0-0-7201" ref-type="bibr">21</xref>). OSA frequently goes unnoticed by people who are at highest risk for developing the disease (<xref rid="b22-etm-0-0-7201" ref-type="bibr">22</xref>&#x2013;<xref rid="b25-etm-0-0-7201" ref-type="bibr">25</xref>). OSA is recognized as a low-grade systemic inflammatory disease; it induces inflammatory responses and can be an indication of metabolic deregulation, in addition to posing a great risk for apoptotic cell death (<xref rid="b26-etm-0-0-7201" ref-type="bibr">26</xref>). Apoptosis can be triggered by two distinct signalling pathways, namely, the intrinsic and extrinsic pathways (<xref rid="b27-etm-0-0-7201" ref-type="bibr">27</xref>,<xref rid="b28-etm-0-0-7201" ref-type="bibr">28</xref>). The intrinsic apoptotic pathway is elicited by a wide range of intracellular stress conditions, including cytokine deprivation, DNA damage, oxidative stress, cytosolic Ca<sup>2&#x002B;</sup> overload and endoplasmic reticulum stress. In the extrinsic pathway, apoptosis is triggered by death receptors, including FAS-associated death domain protein, therefore activating caspases-8 and 10 (the initiator caspases), which in turn activate executioner caspases-3, 6 and 7. In the intrinsic pathway, the mitochondrial permeability transition pore serves a pivotal role in regulating the release of pro-apoptotic proteins, including Cyt-C. The Cyt-C released from mitochondria initiates apoptosome assembly, activating factor 1 and caspase-9, an initiator caspase that cleaves and activates caspases-3 and 7 (<xref rid="b29-etm-0-0-7201" ref-type="bibr">29</xref>).</p>
<p>IH causes mitochondrial and endoplasmic reticulum system damage and produces inflammatory factors that cause lung injury. Sustained and IH-induced cell apoptosis mediates the mitochondrial apoptosis signalling pathway (<xref rid="b30-etm-0-0-7201" ref-type="bibr">30</xref>). A number of hypoxia and inflammatory factors activate caspases via the mitochondrial apoptosis signalling pathway. Mitochondrial morphology is now recognized as an important determinant of the energetic state of mitochondria. IH/hypercapnia leads to oxidative stress due to the mitochondrial response. Mitochondria constantly undergo fusion and fission, which are essential for organelle fidelity. Lung cell apoptosis occurs through a highly regulated proteolytic process that eliminates unwanted, damaged, or altered cells. However, abnormal mitochondrial fission is involved in regulating apoptosis (<xref rid="b31-etm-0-0-7201" ref-type="bibr">31</xref>).</p>
<p>Mdivi-1 has emerged as a critical regulator of cellular function and differentiation under hypoxic conditions. However, the role of mitochondrial dynamics in hypoxia-induced angiogenesis remains to be elucidated. The aim of the present study was to investigate the protective effect and possible mechanism of Mdivi-1 in lung cell apoptosis induced by IH.</p>
<p>Several studies have revealed that Drp-1 participates in mitochondrial fission and the subsequent apoptosis induced by various stimuli (<xref rid="b32-etm-0-0-7201" ref-type="bibr">32</xref>,<xref rid="b33-etm-0-0-7201" ref-type="bibr">33</xref>). Drp-1 assembles from the cytosol onto mitochondria at focal sites of mitochondrial fission; emerging evidence indicates that it is concomitantly involved in apoptosis with mitochondrial outer membrane permeabilization and that Drp-1 inhibition prevents partially intrinsic apoptosis (<xref rid="b34-etm-0-0-7201" ref-type="bibr">34</xref>,<xref rid="b35-etm-0-0-7201" ref-type="bibr">35</xref>). The activity of the prototypical Bcl-2 protein is usually considered anti-apoptotic (<xref rid="b36-etm-0-0-7201" ref-type="bibr">36</xref>). The Bcl-2 family is classified into three subgroups: Pro-apoptotic proteins (Bax, BAD, Bak and Bok); anti-apoptotic proteins (Bcl-2, Bcl-xL and Bcl-w) and BH3-only members [Bad, Bid, Bim, Noxa and PUMA (a p53-upregulated modulator of apoptosis)]. The caspase family of cysteine-aspartic proteases serves an important role in the initiation and completion of cell apoptosis and executes cellular apoptosis. For instance, caspase-3 is the primary activator of apoptotic DNA fragmentation. Certain reports have demonstrated that the pro-apoptotic signalling of Cyt-C triggers the caspase cascade amplification reaction, which leads to the cleavage of a set of proteins (<xref rid="b37-etm-0-0-7201" ref-type="bibr">37</xref>,<xref rid="b38-etm-0-0-7201" ref-type="bibr">38</xref>).</p>
<p>Mitochondria are autonomous and morphologically dynamic organelles that structurally reflect a precise balance of ongoing fission and fusion within a cell. In the two models, <italic>in vitro</italic> and <italic>in vivo</italic>, it was observed that Mdivi-1 decreases mitochondrial fission and inhibits cell apoptosis in the lungs. These results agree with evidence from previous studies (<xref rid="b39-etm-0-0-7201" ref-type="bibr">39</xref>,<xref rid="b40-etm-0-0-7201" ref-type="bibr">40</xref>). In this study, it was demonstrated that inhibiting mitochondrial fission by Mdivi-1 prevents lung apoptosis during IH and it was demonstrated that IH induced mitochondrial fission and apoptosis via a mitochondrial mechanism involving the transcriptional activation of caspase-3, caspase-9 and Drp-1. The results of the present study provide a well-characterized mechanism explaining how IH stimulates mitochondrial fission and consequent apoptosis, which may offer a novel therapeutic strategy for treating OSA via the mitochondrial apoptosis pathway.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec>
<title>Funding</title>
<p>The present study was funded by the Youth Fund Project of Guizhou Provincial People&#x0027;s Hospital (GZSYQN [2016] grant no. 16); the Technology Project of Guizhou Province (contract [2016] No. 2907); the Major Disease Prevention and Control Research of Guizhou Province (contract [2015] grant no. 78); the Science and Technology Project of a tobacco corporation (Guizhou Province division) of China (contract [201608]).</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>The datasets used and/or analysed in the present study are available from the corresponding author upon reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>DZ and XY contributed to the conception and design of the study. CY and ZW collected the data and revised the manuscript for important intellectual content. DZ and XZ analysed and interpreted the data and drafted the manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. The study was approved by the Ethics Committee of Guizhou Provincial People&#x0027;s Hospital.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-etm-0-0-7201"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>T</given-names></name><name><surname>Evans</surname><given-names>L</given-names></name><name><surname>Finn</surname><given-names>L</given-names></name><name><surname>Palta</surname><given-names>M</given-names></name></person-group><article-title>Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women</article-title><source>Sleep</source><volume>20</volume><fpage>705</fpage><lpage>706</lpage><year>1997</year><pub-id pub-id-type="doi">10.1093/sleep/20.9.705</pub-id><pub-id pub-id-type="pmid">9406321</pub-id></element-citation></ref>
<ref id="b2-etm-0-0-7201"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Punjabi</surname><given-names>NM</given-names></name></person-group><article-title>The epidemiology of adult obstructive sleep apnea</article-title><source>Proc Am Thorac Soc</source><volume>5</volume><fpage>136</fpage><lpage>143</lpage><year>2008</year><pub-id pub-id-type="doi">10.1513/pats.200709-155MG</pub-id><pub-id pub-id-type="pmid">18250205</pub-id></element-citation></ref>
<ref id="b3-etm-0-0-7201"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakao</surname><given-names>S</given-names></name><name><surname>Taraseviciene-Stewart</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>JD</given-names></name><name><surname>Wood</surname><given-names>K</given-names></name><name><surname>Cool</surname><given-names>CD</given-names></name><name><surname>Voelkel</surname><given-names>NF</given-names></name></person-group><article-title>Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells</article-title><source>FASEB J</source><volume>19</volume><fpage>1178</fpage><lpage>1180</lpage><year>2005</year><pub-id pub-id-type="doi">10.1096/fj.04-3261fje</pub-id><pub-id pub-id-type="pmid">15897232</pub-id></element-citation></ref>
<ref id="b4-etm-0-0-7201"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haslip</surname><given-names>M</given-names></name><name><surname>Dostanic</surname><given-names>I</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Russell</surname><given-names>KS</given-names></name><name><surname>Jurczak</surname><given-names>MJ</given-names></name><name><surname>Mannam</surname><given-names>P</given-names></name><name><surname>Giordano</surname><given-names>F</given-names></name><name><surname>Erzurum</surname><given-names>SC</given-names></name><name><surname>Lee</surname><given-names>PJ</given-names></name></person-group><article-title>Endothelial Ucp2 regulates mitophagy and pulmonary hypertension during intermittent-hypoxia</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>35</volume><fpage>1166</fpage><lpage>1178</lpage><year>2015</year><pub-id pub-id-type="doi">10.1161/ATVBAHA.114.304865</pub-id><pub-id pub-id-type="pmid">25814675</pub-id></element-citation></ref>
<ref id="b5-etm-0-0-7201"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Miao</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name></person-group><article-title>Metallothionein prevents intermittent hypoxia-induced cardiac endoplasmic reticulum stress and cell death likely via activation of Akt signaling pathway in mice</article-title><source>Toxicol Lett</source><volume>227</volume><fpage>113</fpage><lpage>123</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.toxlet.2014.03.011</pub-id><pub-id pub-id-type="pmid">24680926</pub-id></element-citation></ref>
<ref id="b6-etm-0-0-7201"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>KX</given-names></name><name><surname>Chen</surname><given-names>GP</given-names></name><name><surname>Lin</surname><given-names>PL</given-names></name><name><surname>Huang</surname><given-names>JC</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Qi</surname><given-names>JC</given-names></name><name><surname>Lin</surname><given-names>QC</given-names></name></person-group><article-title>Detection and analysis of apoptosis- and autophagy-related miRNAs of mouse vascular endothelial cells in chronic intermittent hypoxia model</article-title><source>Life Sci</source><volume>193</volume><fpage>194</fpage><lpage>199</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.lfs.2017.11.001</pub-id><pub-id pub-id-type="pmid">29108914</pub-id></element-citation></ref>
<ref id="b7-etm-0-0-7201"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>GC</given-names></name><name><surname>Pan</surname><given-names>YY</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>HG</given-names></name></person-group><article-title>Losartan attenuates aortic endothelial apoptosis induced by chronic intermittent hypoxia partly via the phospholipase C pathway</article-title><source>Sleep Breath</source><volume>21</volume><fpage>679</fpage><lpage>689</lpage><year>2017</year><pub-id pub-id-type="doi">10.1007/s11325-017-1479-4</pub-id><pub-id pub-id-type="pmid">28190165</pub-id></element-citation></ref>
<ref id="b8-etm-0-0-7201"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Hansen</surname><given-names>K</given-names></name><name><surname>Edwards</surname><given-names>R</given-names></name><name><surname>Van Houten</surname><given-names>B</given-names></name><name><surname>Qian</surname><given-names>W</given-names></name></person-group><article-title>Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells</article-title><source>Biochem Biophys Res Commun</source><volume>456</volume><fpage>7</fpage><lpage>12</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2015.09.141</pub-id><pub-id pub-id-type="pmid">25446129</pub-id></element-citation></ref>
<ref id="b9-etm-0-0-7201"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DY</given-names></name><name><surname>Jung</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Ji</surname><given-names>ST</given-names></name><name><surname>Jang</surname><given-names>WB</given-names></name><name><surname>Lamichane</surname><given-names>S</given-names></name><name><surname>Lamichane</surname><given-names>BD</given-names></name><name><surname>Chae</surname><given-names>YC</given-names></name><etal/></person-group><article-title>Hypoxia-dependent mitochondrial fission regulates endothelial progenitor cell migration, invasion, and tube formation</article-title><source>Korean J Physiol Pharmacol</source><volume>22</volume><fpage>203</fpage><lpage>213</lpage><year>2018</year><pub-id pub-id-type="doi">10.4196/kjpp.2018.22.2.203</pub-id><pub-id pub-id-type="pmid">29520173</pub-id></element-citation></ref>
<ref id="b10-etm-0-0-7201"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonder</surname><given-names>JC</given-names></name><name><surname>Laber</surname><given-names>K</given-names></name></person-group><article-title>A renewed look at laboratory rodent housing and management</article-title><source>ILAR J</source><volume>48</volume><fpage>29</fpage><lpage>36</lpage><year>2007</year><pub-id pub-id-type="doi">10.1093/ilar.48.1.29</pub-id><pub-id pub-id-type="pmid">17170493</pub-id></element-citation></ref>
<ref id="b11-etm-0-0-7201"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shortt</surname><given-names>CM</given-names></name><name><surname>Fredsted</surname><given-names>A</given-names></name><name><surname>Chow</surname><given-names>HB</given-names></name><name><surname>Williams</surname><given-names>R</given-names></name><name><surname>Skelly</surname><given-names>JR</given-names></name><name><surname>Edge</surname><given-names>D</given-names></name><name><surname>Bradford</surname><given-names>A</given-names></name><name><surname>O&#x0027;Halloran</surname><given-names>KD</given-names></name></person-group><article-title>Reactive oxygen species mediated diaphragm fatigue in a rat model of chronic intermittent hypoxia</article-title><source>Experiment physiology</source><volume>99</volume><fpage>688</fpage><lpage>700</lpage><year>2014</year><pub-id pub-id-type="doi">10.1113/expphysiol.2013.076828</pub-id></element-citation></ref>
<ref id="b12-etm-0-0-7201"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briancon-Marjollet</surname><given-names>A</given-names></name><name><surname>Monneret</surname><given-names>D</given-names></name><name><surname>Henri</surname><given-names>M</given-names></name><name><surname>Hazane-Puch</surname><given-names>F</given-names></name><name><surname>Pepin</surname><given-names>JL</given-names></name><name><surname>Faure</surname><given-names>P</given-names></name><name><surname>Godin-Ribuot</surname><given-names>D</given-names></name></person-group><article-title>Endothelin regulates intermittent hypoxia-induced lipolytic remodelling of adipose tissue and phosphorylation of hormone-sensitive lipase</article-title><source>J Physiol</source><volume>594</volume><fpage>1727</fpage><lpage>1740</lpage><year>2016</year><pub-id pub-id-type="doi">10.1113/JP271321</pub-id><pub-id pub-id-type="pmid">26663321</pub-id></element-citation></ref>
<ref id="b13-etm-0-0-7201"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poorhassan</surname><given-names>M</given-names></name><name><surname>Navae</surname><given-names>F</given-names></name><name><surname>Mahakizadeh</surname><given-names>S</given-names></name><name><surname>Bazrafkan</surname><given-names>M</given-names></name><name><surname>Nikmehr</surname><given-names>B</given-names></name><name><surname>Abolhassani</surname><given-names>F</given-names></name><name><surname>Ijaz</surname><given-names>S</given-names></name><name><surname>Yamini</surname><given-names>N</given-names></name><name><surname>Dashti</surname><given-names>N</given-names></name><name><surname>Mehrannia</surname><given-names>K</given-names></name><etal/></person-group><article-title>Flaxseed can reduce hypoxia-induced damages in rat testes</article-title><source>Int J Fertil Steril</source><volume>12</volume><fpage>235</fpage><lpage>241</lpage><year>2018</year><pub-id pub-id-type="pmid">29935070</pub-id></element-citation></ref>
<ref id="b14-etm-0-0-7201"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname><given-names>BJ</given-names></name><name><surname>Casanello</surname><given-names>P</given-names></name><name><surname>Dias</surname><given-names>AC</given-names></name><name><surname>Arias</surname><given-names>P</given-names></name><name><surname>Velarde</surname><given-names>V</given-names></name><name><surname>Arenas</surname><given-names>GA</given-names></name><name><surname>Preite</surname><given-names>MD</given-names></name><name><surname>Iturriaga</surname><given-names>R</given-names></name></person-group><article-title>Chronic intermittent hypoxia-Induced vascular dysfunction in rats is reverted by N-Acetylcysteine supplementation and arginase inhibition</article-title><source>Front Physiol</source><volume>9</volume><fpage>901</fpage><year>2018</year><pub-id pub-id-type="doi">10.3389/fphys.2018.00901</pub-id><pub-id pub-id-type="pmid">30087615</pub-id></element-citation></ref>
<ref id="b15-etm-0-0-7201"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>KY</given-names></name><name><surname>Lindsey</surname><given-names>JD</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Heo</surname><given-names>H</given-names></name><name><surname>Nguyen</surname><given-names>DH</given-names></name><name><surname>Ellisman</surname><given-names>MH</given-names></name><name><surname>Weinreb</surname><given-names>RN</given-names></name><name><surname>Ju</surname><given-names>WK</given-names></name></person-group><article-title>A selective inhibitor of drp1, mdivi-1, increases retinal ganglion cell survival in acute ischemic mouse retina</article-title><source>Invest Ophthalmol Vis Sci</source><volume>52</volume><fpage>2837</fpage><lpage>2843</lpage><year>2011</year><pub-id pub-id-type="doi">10.1167/iovs.09-5010</pub-id><pub-id pub-id-type="pmid">21372007</pub-id></element-citation></ref>
<ref id="b16-etm-0-0-7201"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkholder</surname><given-names>T</given-names></name><name><surname>Foltz</surname><given-names>C</given-names></name><name><surname>Karlsson</surname><given-names>E</given-names></name><name><surname>Linton</surname><given-names>CG</given-names></name><name><surname>Smith</surname><given-names>JM</given-names></name></person-group><article-title>Health evaluation of experimental laboratory mice</article-title><source>Curr Protoc Mouse Biol</source><volume>2</volume><fpage>145</fpage><lpage>165</lpage><year>2012</year><pub-id pub-id-type="doi">10.1002/9780470942390.mo110217</pub-id><pub-id pub-id-type="pmid">22822473</pub-id></element-citation></ref>
<ref id="b17-etm-0-0-7201"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostopanagiotou</surname><given-names>G</given-names></name><name><surname>Avgerinos</surname><given-names>E</given-names></name><name><surname>Costopanagiotou</surname><given-names>C</given-names></name><name><surname>Arkadopoulos</surname><given-names>N</given-names></name><name><surname>Andreadou</surname><given-names>I</given-names></name><name><surname>Diamantopoulou</surname><given-names>K</given-names></name><name><surname>Lekka</surname><given-names>M</given-names></name><name><surname>Smyrniotis</surname><given-names>V</given-names></name><name><surname>Nakos</surname><given-names>G</given-names></name></person-group><article-title>Acute lung injury in a rat model of intestinal ischemia-reperfusion: The potential time depended role of phospholipases A(2)</article-title><source>J Surg Res</source><volume>147</volume><fpage>108</fpage><lpage>116</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.jss.2007.07.023</pub-id><pub-id pub-id-type="pmid">17981297</pub-id></element-citation></ref>
<ref id="b18-etm-0-0-7201"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title><source>Method</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></element-citation></ref>
<ref id="b19-etm-0-0-7201"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicole</surname><given-names>NL</given-names></name><name><surname>Satriotomo</surname><given-names>I</given-names></name><name><surname>Harrigan</surname><given-names>DJ</given-names></name><name><surname>Mitchell</surname><given-names>GS</given-names></name></person-group><article-title>Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS</article-title><source>Exp Neurol</source><volume>273</volume><fpage>138</fpage><lpage>150</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.expneurol.2015.08.011</pub-id><pub-id pub-id-type="pmid">26287750</pub-id></element-citation></ref>
<ref id="b20-etm-0-0-7201"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peppard</surname><given-names>PE</given-names></name><name><surname>Young</surname><given-names>T</given-names></name><name><surname>Barnet</surname><given-names>JH</given-names></name><name><surname>Palta</surname><given-names>M</given-names></name><name><surname>Hagen</surname><given-names>EW</given-names></name><name><surname>Hla</surname><given-names>KM</given-names></name></person-group><article-title>Increased prevalence of sleep-disordered breathing in adults</article-title><source>Am J Epidemiol</source><volume>177</volume><fpage>1006</fpage><lpage>10014</lpage><year>2013</year><pub-id pub-id-type="doi">10.1093/aje/kws342</pub-id><pub-id pub-id-type="pmid">23589584</pub-id></element-citation></ref>
<ref id="b21-etm-0-0-7201"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinzer</surname><given-names>R</given-names></name><name><surname>Vat</surname><given-names>S</given-names></name><name><surname>Marques-Vidal</surname><given-names>P</given-names></name><name><surname>Marti-Soler</surname><given-names>H</given-names></name><name><surname>Andries</surname><given-names>D</given-names></name><name><surname>Tobback</surname><given-names>N</given-names></name><name><surname>Mooser</surname><given-names>V</given-names></name><name><surname>Preisig</surname><given-names>M</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>Waeber</surname><given-names>G</given-names></name><etal/></person-group><article-title>Prevalence of sleep-disordered breathing in the general population: The HypnoLaus study</article-title><source>Lancet Respir Med</source><volume>3</volume><fpage>310</fpage><lpage>318</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/S2213-2600(15)00043-0</pub-id><pub-id pub-id-type="pmid">25682233</pub-id></element-citation></ref>
<ref id="b22-etm-0-0-7201"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drager</surname><given-names>LF</given-names></name><name><surname>Togeiro</surname><given-names>SM</given-names></name><name><surname>Polotsky</surname><given-names>VY</given-names></name><name><surname>Lorenzi-Filho</surname><given-names>G</given-names></name></person-group><article-title>Obstructive sleep apnea: A cardiometabolic risk in obesity and the metabolic syndrome</article-title><source>J Am Coll Cardiol</source><volume>62</volume><fpage>569</fpage><lpage>576</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.jacc.2013.05.045</pub-id><pub-id pub-id-type="pmid">23770180</pub-id></element-citation></ref>
<ref id="b23-etm-0-0-7201"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drager</surname><given-names>LF</given-names></name><name><surname>Polotsky</surname><given-names>VY</given-names></name><name><surname>Lorenzi-Filho</surname><given-names>G</given-names></name></person-group><article-title>Obstructive sleep apnea: An emerging risk factor for atherosclerosis</article-title><source>Chest J</source><volume>140</volume><fpage>534</fpage><lpage>542</lpage><year>2011</year><pub-id pub-id-type="doi">10.1378/chest.10-2223</pub-id></element-citation></ref>
<ref id="b24-etm-0-0-7201"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahlin</surname><given-names>C</given-names></name><name><surname>Sandberg</surname><given-names>O</given-names></name><name><surname>Gustafson</surname><given-names>Y</given-names></name><name><surname>Bucht</surname><given-names>G</given-names></name><name><surname>Carlberg</surname><given-names>B</given-names></name><name><surname>Stenlund</surname><given-names>H</given-names></name><name><surname>Franklin</surname><given-names>KA</given-names></name></person-group><article-title>Obstructive sleep apnea is a risk factor for death in patients with stroke: A 10-year follow-up</article-title><source>Arch Intern Med</source><volume>168</volume><fpage>297</fpage><lpage>301</lpage><year>2008</year><pub-id pub-id-type="doi">10.1001/archinternmed.2007.70</pub-id><pub-id pub-id-type="pmid">18268171</pub-id></element-citation></ref>
<ref id="b25-etm-0-0-7201"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name></person-group><article-title>Association of obstructive sleep apnoea with the risk of vascular outcomes and all-cause mortality: A meta-analysis</article-title><source>BMJ Open</source><volume>7</volume><fpage>e013983</fpage><year>2017</year><pub-id pub-id-type="doi">10.1136/bmjopen-2016-013983</pub-id><pub-id pub-id-type="pmid">29275335</pub-id></element-citation></ref>
<ref id="b26-etm-0-0-7201"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zychowski</surname><given-names>KE</given-names></name><name><surname>Sanchez</surname><given-names>B</given-names></name><name><surname>Pedrosa</surname><given-names>RP</given-names></name><name><surname>Lorenzi-Filho</surname><given-names>G</given-names></name><name><surname>Drager</surname><given-names>LF</given-names></name><name><surname>Polotsky</surname><given-names>VY</given-names></name><name><surname>Campen</surname><given-names>MJ</given-names></name></person-group><article-title>Serum from obstructive sleep apnea patients induces inflammatory responses in coronary artery endothelial cells</article-title><source>Atherosclerosis</source><volume>254</volume><fpage>59</fpage><lpage>66</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2016.09.017</pub-id><pub-id pub-id-type="pmid">27693879</pub-id></element-citation></ref>
<ref id="b27-etm-0-0-7201"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galluzzi</surname><given-names>L</given-names></name><name><surname>Vitale</surname><given-names>I</given-names></name><name><surname>Abrams</surname><given-names>JM</given-names></name><name><surname>Alnemri</surname><given-names>ES</given-names></name><name><surname>Baehrecke</surname><given-names>EH</given-names></name><name><surname>Blagosklonny</surname><given-names>MV</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name><name><surname>Dawson</surname><given-names>VL</given-names></name><name><surname>El-Deiry</surname><given-names>WS</given-names></name><name><surname>Fulda</surname><given-names>S</given-names></name><etal/></person-group><article-title>Molecular definitions of cell death subroutines: Recommendations of the nomenclature committee on cell death 2012</article-title><source>Cell Death Differ</source><volume>19</volume><fpage>107</fpage><lpage>120</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/cdd.2011.96</pub-id><pub-id pub-id-type="pmid">21760595</pub-id></element-citation></ref>
<ref id="b28-etm-0-0-7201"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmore</surname><given-names>S</given-names></name></person-group><article-title>Apoptosis: A review of programmed cell death</article-title><source>Toxicol Pathol</source><volume>35</volume><fpage>495</fpage><lpage>516</lpage><year>2007</year><pub-id pub-id-type="doi">10.1080/01926230701320337</pub-id><pub-id pub-id-type="pmid">17562483</pub-id></element-citation></ref>
<ref id="b29-etm-0-0-7201"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mari&#x00F1;o</surname><given-names>G</given-names></name><name><surname>Niso-Santano</surname><given-names>M</given-names></name><name><surname>Baehrecke</surname><given-names>EH</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Self-consumption: The interplay of autophagy and apoptosis</article-title><source>Nat Rev Mol Cell Biol</source><volume>15</volume><fpage>81</fpage><lpage>94</lpage><year>2014</year><pub-id pub-id-type="doi">10.1038/nrm3735</pub-id><pub-id pub-id-type="pmid">24401948</pub-id></element-citation></ref>
<ref id="b30-etm-0-0-7201"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>RM</given-names></name><name><surname>Ryu</surname><given-names>J</given-names></name><name><surname>Kanaan</surname><given-names>A</given-names></name><name><surname>Del Carmen Rivero</surname><given-names>M</given-names></name><name><surname>Dugan</surname><given-names>LL</given-names></name><name><surname>Haddad</surname><given-names>GG</given-names></name><name><surname>Ali</surname><given-names>SS</given-names></name></person-group><article-title>Neuronal death during combined intermittent hypoxia/hypercapnia is due to mitochondrial dysfunction</article-title><source>Am J Physiol Cell Physiol</source><volume>298</volume><fpage>C1594</fpage><lpage>C1602</lpage><year>2012</year><pub-id pub-id-type="doi">10.1152/ajpcell.00298.2009</pub-id></element-citation></ref>
<ref id="b31-etm-0-0-7201"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Donath</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>D</given-names></name><name><surname>Prabhakar</surname><given-names>BS</given-names></name><name><surname>Li</surname><given-names>P</given-names></name></person-group><article-title>miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway</article-title><source>PLoS Genet</source><volume>6</volume><fpage>e1000795</fpage><year>2010</year><pub-id pub-id-type="doi">10.1371/journal.pgen.1000795</pub-id><pub-id pub-id-type="pmid">20062521</pub-id></element-citation></ref>
<ref id="b32-etm-0-0-7201"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>JR</given-names></name><name><surname>Gao</surname><given-names>PJ</given-names></name></person-group><article-title>Mitochondrial division inhibitor Mdivi-1 ameliorates angiotensin II-induced endothelial dysfunction</article-title><source>Sheng Li Xue Bao</source><volume>68</volume><fpage>669</fpage><lpage>676</lpage><year>2016</year><pub-id pub-id-type="pmid">27778033</pub-id></element-citation></ref>
<ref id="b33-etm-0-0-7201"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oettinghaus</surname><given-names>B</given-names></name><name><surname>D&#x0027;Alonzo</surname><given-names>D</given-names></name><name><surname>Barbieri</surname><given-names>E</given-names></name><name><surname>Restelli</surname><given-names>LM</given-names></name><name><surname>Savoia</surname><given-names>C</given-names></name><name><surname>Licci</surname><given-names>M</given-names></name><name><surname>Tolnay</surname><given-names>M</given-names></name><name><surname>Frank</surname><given-names>S</given-names></name><name><surname>Scorrano</surname><given-names>L</given-names></name></person-group><article-title>DRP1-dependent apoptotic mitochondrial fission occurs independently of BAX, BAK and APAF1 to amplify cell death by BID and oxidative stress</article-title><source>Biochim Biophys Acta 1857</source><fpage>1267</fpage><lpage>1276</lpage><year>2016</year></element-citation></ref>
<ref id="b34-etm-0-0-7201"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>A</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis</article-title><source>Mol Cell</source><volume>29</volume><fpage>409</fpage><lpage>410</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.molcel.2008.02.005</pub-id><pub-id pub-id-type="pmid">18313377</pub-id></element-citation></ref>
<ref id="b35-etm-0-0-7201"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>S</given-names></name><name><surname>Gaume</surname><given-names>B</given-names></name><name><surname>Bergmann-Leitner</surname><given-names>ES</given-names></name><name><surname>Leitner</surname><given-names>WW</given-names></name><name><surname>Robert</surname><given-names>EG</given-names></name><name><surname>Catez</surname><given-names>F</given-names></name><name><surname>Smith</surname><given-names>CL</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis</article-title><source>Dev Cell</source><volume>1</volume><fpage>515</fpage><lpage>525</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S1534-5807(01)00055-7</pub-id><pub-id pub-id-type="pmid">11703942</pub-id></element-citation></ref>
<ref id="b36-etm-0-0-7201"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czabotar</surname><given-names>PE</given-names></name><name><surname>Lessene</surname><given-names>G</given-names></name><name><surname>Strasser</surname><given-names>A</given-names></name><name><surname>Adams</surname><given-names>JM</given-names></name></person-group><article-title>Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy</article-title><source>Nat Rev Mol Cell Biol</source><volume>15</volume><fpage>49</fpage><lpage>63</lpage><year>2014</year><pub-id pub-id-type="doi">10.1038/nrm3722</pub-id><pub-id pub-id-type="pmid">24355989</pub-id></element-citation></ref>
<ref id="b37-etm-0-0-7201"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Pietro</surname><given-names>R</given-names></name><name><surname>Zauli</surname><given-names>G</given-names></name></person-group><article-title>Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L</article-title><source>J Cell Physiol</source><volume>201</volume><fpage>331</fpage><lpage>340</lpage><year>2004</year><pub-id pub-id-type="doi">10.1002/jcp.20099</pub-id><pub-id pub-id-type="pmid">15389537</pub-id></element-citation></ref>
<ref id="b38-etm-0-0-7201"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sikora</surname><given-names>E</given-names></name><name><surname>Bielak-Zmijewska</surname><given-names>A</given-names></name><name><surname>Magalska</surname><given-names>A</given-names></name><name><surname>Piwocka</surname><given-names>K</given-names></name><name><surname>Mosieniak</surname><given-names>G</given-names></name><name><surname>Kalinowska</surname><given-names>M</given-names></name><name><surname>Widlak</surname><given-names>P</given-names></name><name><surname>Cymerman</surname><given-names>IA</given-names></name><name><surname>Bujnicki</surname><given-names>JM</given-names></name></person-group><article-title>Curcumin induces caspase-3-dependent apoptotic pathway but inhibits DNA fragmentation factor 40/caspase-activated DNase endonuclease in human Jurkat cells</article-title><source>Mol Cancer Ther</source><volume>5</volume><fpage>927</fpage><lpage>934</lpage><year>2006</year><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-05-0360</pub-id><pub-id pub-id-type="pmid">16648563</pub-id></element-citation></ref>
<ref id="b39-etm-0-0-7201"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>XJ</given-names></name><name><surname>Yang</surname><given-names>ZJ</given-names></name><name><surname>Jiang</surname><given-names>LP</given-names></name><name><surname>Wei</surname><given-names>YF</given-names></name><name><surname>Liao</surname><given-names>MF</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>JB</given-names></name><name><surname>Xin</surname><given-names>HB</given-names></name><name><surname>Wan</surname><given-names>YY</given-names></name></person-group><article-title>Mitochondrial dynamics regulates hypoxia-induced migration and antineoplastic activity of cisplatin in breast cancer cells</article-title><source>Int J Oncol</source><volume>46</volume><fpage>691</fpage><lpage>700</lpage><year>2015</year><pub-id pub-id-type="doi">10.3892/ijo.2014.2781</pub-id><pub-id pub-id-type="pmid">25434519</pub-id></element-citation></ref>
<ref id="b40-etm-0-0-7201"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>TH</given-names></name><name><surname>Raghunayakula</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name></person-group><article-title>Neuronal hypoxia disrupts mitochondrial fusion</article-title><source>Neuroscience</source><volume>301</volume><fpage>71</fpage><lpage>78</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.05.078</pub-id><pub-id pub-id-type="pmid">26049142</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-etm-0-0-7201" position="float">
<label>Figure 1.</label>
<caption><p>Detection of variations in the lung media of rats in each group using haematoxylin and eosin staining (magnification, 400; scale bar, 50 &#x00B5;m). (A) The control group, n=8. (B) The IH group, n=8. (C) The IH&#x002B;25 mg/kg Mdivi-1 group, n=8. (D) IH&#x002B;50 mg/kg Mdivi-1 group, n=8. (E) Compared with normoxia, IH caused interstitial alterations in the lung tissues of SD rats, while Mdivi-1 significantly reduced the pulmonary interstitial lesions. The effects in the IH&#x002B;50 mg/kg Mdivi-1 group were more obvious than those in the IH&#x002B;25 mg/kg Mdivi-1 group. IH, intermittent hypoxia; SD, Sprague Dawley; Mdivi, mitochondrial division inhibitor-1. &#x002A;P&#x003C;0.05 vs. group C; <sup>#</sup>P&#x003C;0.05 vs. group IH.</p></caption>
<graphic xlink:href="etm-17-03-2349-g00.tif"/>
</fig>
<fig id="f2-etm-0-0-7201" position="float">
<label>Figure 2.</label>
<caption><p>Detection of Bcl-2, caspase-3, caspase-9, Drp-1 and Cyt-C expression levels in rats lungs via reverse transcription-quantitative polymerase chain reaction. (A) Bcl-2 levels. (B) Caspase-3 levels. (C) Caspase-9 levels. (D) Drp-1 levels. (E) Cyt-C levels. Compared with those of group C, Bcl-2 mRNA levels were decreased, but caspase-3 and caspase-9 mRNA levels were increased in the IH group, and these differences were statistically significant &#x002A;P&#x003C;0.05 vs. group C. Compared with those of the IH group, Bcl-2 mRNA levels were increased and caspase-3 and Drp-1 mRNA levels were decreased in the IH&#x002B;50 mg/kg Mdivi-1 group, <sup>#</sup>P&#x003C;0.05 vs. the IH group. IH, intermittent hypoxia; Mdivi, mitochondrial division inhibitor-1; Bcl, B-cell lymphoma; Cyt-c, cytochrome C; group C, control group.</p></caption>
<graphic xlink:href="etm-17-03-2349-g01.tif"/>
</fig>
<fig id="f3-etm-0-0-7201" position="float">
<label>Figure 3.</label>
<caption><p>Detection of Bcl-2, caspase-3, caspase-9, Drp-1 and Cyt-C expression levels in WTRL1 cells via reverse transcription-quantitative polymerase chain reaction. (A) Bcl-2 levels. (B) Caspase-3 levels. (C) Caspase-9 levels. (D) Drp-1 levels. (E) Cyt-C levels. Compared with those in group C, Bcl-2 mRNA levels were lower, but caspase-3 and caspase-9 mRNA levels were higher in the IH group, and these differences were statistically significant &#x002A;P&#x003C;0.05 vs. group C. Compared with those in the IH group, Bcl-2 mRNA expression levels were increased and caspase-3, and Drp-1 mRNAs were decreased After Mdivi-1 intervention, <sup>#</sup>P&#x003C;0.05 vs. the IH group. IH, intermittent hypoxia; Mdivi, mitochondrial division inhibitor-1; Bcl, B-cell lymphoma; Cyt-c, cytochrome C; group C, control group.</p></caption>
<graphic xlink:href="etm-17-03-2349-g02.tif"/>
</fig>
<fig id="f4-etm-0-0-7201" position="float">
<label>Figure 4.</label>
<caption><p>Detection of Bcl-2, caspase-3, caspase-9, Cyt-C and Drp-1 protein expression levels in rat lungs via western blotting assays. (A) (Lane 1) Group C, n-8. (Lane 2) IH group, n=8. (Lane 3) IH&#x002B;25 mg/kg Mdivi-1 group, n=8. (Lane 4) IH&#x002B;50 mg/kg Mdivi-1 group, n=8. Compared with that in the group C, the protein expression of (B) Bcl-2 in the IH group was decreased and that of (C) caspase-3, (D) caspase-9 and (E) Drp-1 was increased in the IH group. (F) The changes in protein expression of Cyt C were not significant. &#x002A;P&#x003C;0.05 vs. group C. Compared with the IH group, the protein expression of Bcl-2 was increased and caspase-3, caspase-9, and Drp-1 was decreased in the IH&#x002B;50 mg/kg Mdivi-1 group, <sup>#</sup>P&#x003C;0.05 vs. IH. IH, intermittent hypoxia; Mdivi, mitochondrial division inhibitor-1; Bcl, B-cell lymphoma; Cyt-c, cytochrome C; group C, control group.</p></caption>
<graphic xlink:href="etm-17-03-2349-g03.tif"/>
</fig>
<fig id="f5-etm-0-0-7201" position="float">
<label>Figure 5.</label>
<caption><p>Detection of Bcl-2, caspase-3, caspase-9, Cyt-C and Drp-1 expression levels in WTRL1 cells via western blotting assays. (A) (Lane 1) Group C, n-8. (Lane 2) IH group, n=8. (Lane 3) IH&#x002B;10 &#x00B5;M Mdivi-1 group, n=8. (Lane 4) IH&#x002B;50 &#x00B5;M Mdivi-1 group, n=8. (Lane 5) IH&#x002B;100 &#x00B5;M Mdivi-1 group, n=8. Compared with the group C, (B) Bcl-2 protein expression in the IH group was decreased, but (C) caspase-3, (D) caspase-9 and (E) Drp-1 protein expression was increased, &#x002A;P&#x003C;0.05 vs. group C. Compared with the IH group, Bcl-2 protein expression was increased and caspase-9 Drp-1 and (F) Cyt-C protein expression was decreased in the IH&#x002B;100 &#x00B5;M Mdivi-1 group, <sup>#</sup>P&#x003C;0.05 vs. IH. Mdivi, mitochondrial division inhibitor-1; Drp-1, dynamin-related protein 1; IH, intermittent hypoxia; Bcl, B-cell lymphoma; group C, Control group.</p></caption>
<graphic xlink:href="etm-17-03-2349-g04.tif"/>
</fig>
<fig id="f6-etm-0-0-7201" position="float">
<label>Figure 6.</label>
<caption><p>Detection of the apoptosis rate via flow cytometry. (A) Group C, n=8. (B) IH for 6 h, n=8. (C) IH for 12 h, n=8. (D) IH for 24 h, n=8. (E) IH for 48 h, n=8. (F) Detection of the apoptosis rate via flow cytometry. The apoptosis rate of WTRL1 cells increased gradually with the time exposed to IH and the apoptosis rate was the highest at 48 h. &#x002A;P&#x003C;0.05 vs. group C. IH, intermittent hypoxia; group C, control group.</p></caption>
<graphic xlink:href="etm-17-03-2349-g05.tif"/>
</fig>
<table-wrap id="tI-etm-0-0-7201" position="float">
<label>Table I.</label>
<caption><p>Assessing pain and distress in animal.</p></caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<td align="left" valign="top">1) No indication of pain and distress</td>
<td align="left" valign="top">Normal; well groomed; alert; active; good condition; asleep or calm; normal appetite; BCS=3, 4 or 5</td>
</tr>
<tr>
<td align="left" valign="top">2) Mild or anticipated pain and distress</td>
<td align="left" valign="top">Not well groomed; awkward gait; slightly hunched; looks at wound or pulls away when area touched; mildly agitated; BCS=2</td>
</tr>
<tr>
<td align="left" valign="top">3) Moderate pain and distress</td>
<td align="left" valign="top">Rough hair coat; dirty incision; squinted eyes; moves slowly; walks hunched and/or slowly; depressed or moderately agitated; slight dehydration; pruritic; restless; uncomfortable; not eating or drinking; BCS=2.</td>
</tr>
<tr>
<td align="left" valign="top">4) Severe pain and distress</td>
<td align="left" valign="top">Very rough hair coat; eyes sunken (severe dehydration); slow to move or non-responsive when coaxed; hunched; large abdominal mass; dyspnea; self mutilating; violent reaction to stimuli or when approached; BCS=1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-etm-0-0-7201"><p>BCS, body condition score.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-etm-0-0-7201" position="float">
<label>Table II.</label>
<caption><p>Primer sequences for reverse transcription-quantitative polymerase chain reaction.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Primer name</th>
<th align="center" valign="bottom">Primer sequence (5&#x2032;-3&#x2032;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">GAPDH</td>
<td align="left" valign="top">F: AGCCACATCGCTCAGACAC</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: GCCCAATACGACCAATCC</td>
</tr>
<tr>
<td align="left" valign="top">B-cell lymphoma 2</td>
<td align="left" valign="top">F: TCCTTCCAGCCTGAGAGCAACC</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: TCACGACGGTAGCGACGAGAG</td>
</tr>
<tr>
<td align="left" valign="top">Caspase-3</td>
<td align="left" valign="top">F: GTAGCAGTGTGCCGCTGTGTC</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: ACTCTTGTCCATCGCCTCTCCTC</td>
</tr>
<tr>
<td align="left" valign="top">Caspase-9</td>
<td align="left" valign="top">F: ATGGAGGAGGCTGACCGGCAACTCCTG</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: TCATGAAGTTTTAAAGAACAGCTTCTTC</td>
</tr>
<tr>
<td align="left" valign="top">Cytochrome C</td>
<td align="left" valign="top">F: AGGAGGCAAGCATAAGAC</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: ATTAGGTCTGCCCTTTCT</td>
</tr>
<tr>
<td align="left" valign="top">Dynamin-related protein 1</td>
<td align="left" valign="top">F: TTCGCCGCCTGGAGGACC</td>
</tr>
<tr>
<td/>
<td align="left" valign="top">R: CACTTCGTTGCCACAATGCTGAA</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2-etm-0-0-7201"><p>F, forward; R, reverse.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
